Targeted-Agent Continual Reassessment Method: A Novel Bayesian Enrichment Design for Phase I Trials of Molecularly Targeted Therapies
JCO Precis Oncol. 2024 Dec;8:e2400360. doi: 10.1200/PO.24.00360. Epub 2024 Dec 23. ABSTRACT PURPOSE: Novel therapies targeting specific genomic alterations are a promising treatment approach for …